Open AccessThe role of FSH to AMH ratio in poor prognosis patients undergoing ICSI cycle
Author(s) -
İlay Gözükara,
Nafiye Yılmaz,
Mehmet Ufuk Ceran,
Ece Atalay,
Serkan Kahyaoğlu,
Hacer Cavidan Gülerman,
Yaprak Engin Üstün
Publication year - 2022
Publication title -
journal of the turkish-german gynecological association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.346
H-Index - 16
eISSN - 1309-0399
pISSN - 1309-0380
DOI - 10.4274/jtgga.galenos.2022.2021-9-19
Subject(s) - intracytoplasmic sperm injection , medicine , oocyte , antral follicle , confidence interval , anti müllerian hormone , gonadotropin , andrology , gynecology , follicle stimulating hormone , live birth , pregnancy , hormone , obstetrics , in vitro fertilisation , biology , luteinizing hormone , embryo , genetics , microbiology and biotechnology
The objective of this study was to estimate the number of oocyte retrieval and cycle cancellation using follicle stimulating hormone (FSH) to anti-Mullerian hormone (AMH) ratio in poor prognosis patients undergoing intracytoplasmic sperm injection treatment.